Get the Stockscreener App
3.8629
8.71%
0.3029
Pyxis Oncology Inc stock is traded at $3.8629, with a volume of 1.57M.
It is up +8.71% in the last 24 hours and up +50.58% over the past month.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
See More
Previous Close:
$3.56
Open:
$3.48
24h Volume:
1.57M
Relative Volume:
2.16
Market Cap:
$239.39M
Revenue:
-
Net Income/Loss:
$-73.79M
P/E Ratio:
-2.0994
EPS:
-1.84
Net Cash Flow:
$-77.44M
1W Performance:
+14.16%
1M Performance:
+50.58%
6M Performance:
+207.14%
1Y Performance:
+2.93%
1-Day Range:
$3.48
$4.15
1-Week Range:
$3.26
$4.15
52-Week Range:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Name
Pyxis Oncology Inc
Sector
Industry
Phone
(617) 221-9059
Address
321 HARRISON AVENUE, BOSTON
Compare PYXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
3.86 | 220.78M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.76 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.33 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.40 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.30 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.16 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | Guggenheim | Buy |
| Nov-21-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-08-24 | Initiated | Stephens | Overweight |
| Aug-08-24 | Initiated | Stifel | Buy |
| May-07-24 | Resumed | Jefferies | Buy |
| Feb-09-24 | Initiated | BTIG Research | Buy |
| Jan-23-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-02-21 | Initiated | BofA Securities | Neutral |
| Nov-02-21 | Initiated | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Jefferies | Buy |
View All
Pyxis Oncology Inc Stock (PYXS) Latest News
What analyst consensus says on Pyxis Oncology Inc. stockTrade Performance Summary & Precise Swing Trade Alerts - newser.com
Backtesting results for Pyxis Oncology Inc. trading strategiesM&A Rumor & Safe Investment Capital Preservation Plans - newser.com
Applying Elliott Wave Theory to Pyxis Oncology Inc.2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Can trapped investors hope for a rebound in Pyxis Oncology Inc.2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Pyxis Oncology Keeps Losses Steady As It Eyes Key Trial Data - Finimize
Will Pyxis Oncology Inc. stock split again soon2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Is Pyxis Oncology Inc. stock bottoming outMarket Performance Report & Verified Short-Term Plans - newser.com
Is Pyxis Oncology Inc. stock cheap at current valuationJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com
Why Pyxis Oncology Inc. stock remains undervaluedRecession Risk & High Return Stock Watch Alerts - newser.com
Ranking Pyxis Oncology Inc. among high performing stocks via toolsJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
Pyxis Oncology, Inc. SEC 10-Q Report - TradingView
Tick level data insight on Pyxis Oncology Inc. volatility2025 Sector Review & Precise Swing Trade Alerts - newser.com
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewswire
Published on: 2025-11-03 05:42:22 - newser.com
Will Pyxis Oncology Inc. stock benefit from AI adoptionMarket Movers & AI Optimized Trading Strategy Guides - newser.com
Is Pyxis Oncology Inc. stock a bargain at current levelsTrade Entry Report & AI Forecasted Stock Moves - newser.com
How to manage a losing position in Pyxis Oncology Inc.July 2025 Snapshot & Safe Capital Allocation Plans - newser.com
How Pyxis Oncology Inc. stock reacts to global recession fearsGDP Growth & Pattern Based Trade Signal System - newser.com
Why Pyxis Oncology Inc. stock is a value investor pickTrade Analysis Report & Expert Curated Trade Setup Alerts - newser.com
Will Pyxis Oncology Inc. stock deliver better than expected guidanceEarnings Overview Summary & Low Volatility Stock Suggestions - newser.com
How risky is Pyxis Oncology Inc. stock nowQuarterly Profit Review & Target Return Focused Stock Picks - newser.com
Can Pyxis Oncology Inc. stock beat analyst upgrades2025 Year in Review & Real-Time Volume Analysis Alerts - newser.com
What makes Pyxis Oncology Inc. stock attractive to growth fundsTake Profit & Weekly Breakout Stock Alerts - newser.com
Will Pyxis Oncology Inc. stock continue upward momentum2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
When is the best time to exit Pyxis Oncology Inc.2025 Price Momentum & Daily Market Momentum Tracking - newser.com
Custom watchlist performance reports with Pyxis Oncology Inc.M&A Rumor & Consistent Growth Stock Picks - newser.com
Published on: 2025-11-02 01:36:01 - newser.com
Will breakout in Pyxis Oncology Inc. lead to full recoveryMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Is Pyxis Oncology Inc. stock gaining market shareMarket Risk Report & Safe Entry Momentum Stock Tips - newser.com
Using flow based indicators on Pyxis Oncology Inc.Market Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
Pyxis Oncology Inc Stock (PYXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.33%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):